Christina Runge, PhD, CCC-A

Publications

• In vivo biodistribution and ototoxicity assessment of cationic liposomal-ceftriaxone via noninvasive trans-tympanic delivery in chinchilla models: Implications for otitis media therapy.

  (Shafiee S, Hong W, Lucas J, Khampang P, Runge CL, Wells C, Yan K, Kerschner JE, Joshi A.) Int J Pediatr Otorhinolaryngol. 2024 Mar;178:111894 PMID: 38350381 PMCID: PMC10939715 SCOPUS ID: 2-s2.0-85185718661 02/14/2024

• Chronic tympanic membrane perforation repair with a collagen-based scaffold: An in vivo model.

  (Harvey EA, Hong W, Sheehy EJ, do Amaral RJ, Khampang P, Runge CL, O'Leary C, O'Brien FJ, Kerschner JE.) Int J Pediatr Otorhinolaryngol. 2024 Jan;176:111807 PMID: 38134588 SCOPUS ID: 2-s2.0-85180588125 12/22/2023

• Cochlear Implant Performance in Candidates With Moderate Hearing Loss Qualifying in Noise.

  (Friedland DR, Kozlowski K, Runge CL.) Otol Neurotol. 2021 Dec 01;42(10):1484-1491 PMID: 34310553 SCOPUS ID: 2-s2.0-85121957978 07/27/2021

• Improved Speech Intelligibility in Subjects With Stable Sensorineural Hearing Loss Following Intratympanic Dosing of FX-322 in a Phase 1b Study.

  (McLean WJ, Hinton AS, Herby JTJ, Salt AN, Hartsock JJ, Wilson S, Lucchino DL, Lenarz T, Warnecke A, Prenzler N, Schmitt H, King S, Jackson LE, Rosenbloom J, Atiee G, Bear M, Runge CL, Gifford RH, Rauch SD, Lee DJ, Langer R, Karp JM, Loose C, LeBel C.) Otol Neurotol. 2021 Aug 01;42(7):e849-e857 PMID: 33617194 PMCID: PMC8279894 SCOPUS ID: 2-s2.0-85107730392 02/23/2021

• A Longitudinal Comparison of Environmental Sound Recognition in Adults With Hearing Aids Before and After Cochlear Implantation.

  (Harris MS, Moberly AC, Hamel BL, Vasil K, Runge CL, Riggs WJ, Shafiro V.) J Speech Lang Hear Res. 2021 Mar 17;64(3):1040-1052 PMID: 33651956 PMCID: PMC8608242 SCOPUS ID: 2-s2.0-85102884339 03/03/2021

• Auditory brainstem responses in aging dark agouti rats.

  (Beltrame AK, Dahms NM, Runge CL.) Biosci Rep. 2021 Feb 26;41(2) PMID: 33506259 PMCID: PMC7897922 SCOPUS ID: 2-s2.0-85102217469 01/29/2021

• Results of a 2-Year Prospective Multicenter Study Evaluating Long-term Audiological and Clinical Outcomes of a Transcutaneous Implant for Bone Conduction Hearing.

  (Kruyt IJ, Monksfield P, Skarzynski PH, Green K, Runge C, Bosman A, Blechert JI, Wigren S, Mylanus EAM, Hol MKS.) Otol Neurotol. 2020 Aug;41(7):901-911 PMID: 32310837 PMCID: PMC7373438 SCOPUS ID: 2-s2.0-85088486999 04/21/2020

• Development of in-house genetic screening for pediatric hearing loss.

  (Doerfer KW, Sander T, Konduri GG, Friedland DR, Kerschner JE, Runge CL.) Laryngoscope Investig Otolaryngol. 2020 Jun;5(3):497-505 PMID: 32596493 PMCID: PMC7314470 07/01/2020

• Update on Auditory Neuropathy/Dyssynchrony in Children

  (Roman AN, Runge CL.) Current Otorhinolaryngology Reports. September 2020;8(3):276-284 SCOPUS ID: 2-s2.0-85100614201 09/01/2020

• Audiological and clinical outcomes of a transcutaneous bone conduction hearing implant: Six-month results from a multicentre study.

  (den Besten CA, Monksfield P, Bosman A, Skarzynski PH, Green K, Runge C, Wigren S, Blechert JI, Flynn MC, Mylanus EAM, Hol MKS.) Clin Otolaryngol. 2019 Mar;44(2):144-157 PMID: 30358920 SCOPUS ID: 2-s2.0-85056761069 10/26/2018

• Improved Speech Perception in Cochlear Implant Users With Interleaved High-Rate Pulse Trains.

  (Runge CL, Du F, Hu Y.) Otol Neurotol. 2018 Jun;39(5):e319-e324 PMID: 29649048 SCOPUS ID: 2-s2.0-85048081634 04/13/2018

• TMTC2 variant associated with sensorineural hearing loss and auditory neuropathy spectrum disorder in a family dyad.

  (Guillen-Ahlers H, Erbe CB, Chevalier FD, Montoya MJ, Zimmerman KD, Langefeld CD, Olivier M, Runge CL.) Mol Genet Genomic Med. 2018 Apr 19;6(4):653-9 PMID: 29671961 PMCID: PMC6081214 04/20/2018